Health ❯ Clinical Trials

Gene Therapy

Wet Age-Related Macular Degeneration (AMD) Patient Outcomes ANGPTL3 Gene FDA Approval FDA Regulations Heart Disease CRISPR Sickle Cell Disease Heart Failure Treatment Cell Therapy Patient Treatment

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in Securities Suit

Plaintiffs tie losses to FDA trial holds disclosed Jan. 28 after a reported tumor in a participant.